Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP866428.RAvQEyOuyfLfJdBIbzRph8Y1Ribo7swwoSBq-WmvlR8I0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP866428.RAvQEyOuyfLfJdBIbzRph8Y1Ribo7swwoSBq-WmvlR8I0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP866428.RAvQEyOuyfLfJdBIbzRph8Y1Ribo7swwoSBq-WmvlR8I0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP866428.RAvQEyOuyfLfJdBIbzRph8Y1Ribo7swwoSBq-WmvlR8I0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP866428.RAvQEyOuyfLfJdBIbzRph8Y1Ribo7swwoSBq-WmvlR8I0130_provenance.
- NP866428.RAvQEyOuyfLfJdBIbzRph8Y1Ribo7swwoSBq-WmvlR8I0130_assertion wasGeneratedBy ECO_0000203 NP866428.RAvQEyOuyfLfJdBIbzRph8Y1Ribo7swwoSBq-WmvlR8I0130_provenance.
- NP866428.RAvQEyOuyfLfJdBIbzRph8Y1Ribo7swwoSBq-WmvlR8I0130_assertion wasDerivedFrom befree-20150227 NP866428.RAvQEyOuyfLfJdBIbzRph8Y1Ribo7swwoSBq-WmvlR8I0130_provenance.
- NP866428.RAvQEyOuyfLfJdBIbzRph8Y1Ribo7swwoSBq-WmvlR8I0130_assertion SIO_000772 23403405 NP866428.RAvQEyOuyfLfJdBIbzRph8Y1Ribo7swwoSBq-WmvlR8I0130_provenance.
- NP866428.RAvQEyOuyfLfJdBIbzRph8Y1Ribo7swwoSBq-WmvlR8I0130_assertion evidence source_evidence_literature NP866428.RAvQEyOuyfLfJdBIbzRph8Y1Ribo7swwoSBq-WmvlR8I0130_provenance.
- NP866428.RAvQEyOuyfLfJdBIbzRph8Y1Ribo7swwoSBq-WmvlR8I0130_assertion description "[The seminal observations leading to these discoveries were the following: 1) mutations in FGF23 cause ADHR by limiting cleavage of the bioactive intact molecule, at a subtilisin-like protein convertase (SPC) site, resulting in increased circulating FGF23 levels and hypophosphatemia; 2) mutations in DMP1 cause ARHR, not only by increasing serum FGF23, albeit by enhanced production and not limited cleavage, but also by limiting production of the active DMP1 component, the C-terminal fragment, resulting in dysregulated production of DKK1 and β-catenin, which contributes to impaired bone mineralization; and 3) mutations in PHEX cause XLH both by altering FGF23 proteolysis and production and causing dysregulated production of DKK1 and β-catenin, similar to abnormalities in ADHR and ARHR, but secondary to different central pathophysiological events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866428.RAvQEyOuyfLfJdBIbzRph8Y1Ribo7swwoSBq-WmvlR8I0130_provenance.